3368 Peachtree Rd. Achieving Effective Recognition and Management of Spinal Muscular Atrophy: How Does Your Approach Compare with the Experts? Where Are We With Multi-Cancer Early Detection Technologies? Discussion will include mechanisms of action, emerging clinical data, best practices in screening patients, and management considerations for hyperkalemia. 1,502 Med Learning Group Clinical Education $85,000 jobs available on Indeed.com. In this virtual program, we will explore the management of Parkinsons disease psychosis (PDP)a condition that affects a substantial percentage of patients with Parkinsons disease, typically in the later stages. Atopic Dermatitis: Targeting Underlying Inflammatory Pathways with Systemic Therapy THE THRIVE INITIATIVE, Moderate-to-Severe Asthma: Targeting Underlying Inflammatory Processes to Improve Patient Outcomes, Advances in the Therapeutic Management of Patients with Chronic Hematological Conditions A Whiteboard Preceptorship, Understanding Cervical Biology and Oncogenesis: Leveraging Checkpoint Inhibition in Recurrent and Metastatic Disease, Treatment Priorities in Systemic Lupus Erythematosus: Focus on Musculoskeletal Symptoms and Patient-Reported Outcomes, A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies, A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies. We cannot thank you enough for your courage and selfless service. We are currently looking for both full and part-time clinicians to join our team! Expert Perspectives on Managing Moderate-to-Severe Atopic Dermatitis in Pediatric and Adult Patients, Advances in the Treatment of Patients with Systemic Lupus Erythematosus: Leveraging its Pathogenic Pathways to Improve Outcomes, Opportunities for Nephrology Fellows to Innovate on CKD risk in Patients With T2D: Novel Developments in Mineralocorticoid Antagonists, Disease Modification in Individuals with Moderate-to-Severe Rheumatoid Arthritis: Optimizing Treatment Through the Finely Tuned Selectivity for JAKs, Therapeutic Options in Hepatorenal Syndrome with Acute Kidney Injury: Confirming the Value of Systemic Vasoconstriction, Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs, New Strategies for Reducing Cardiovascular Risk in CKD with T2D: Development of Finer Mineralocorticoid Antagonists, Moderate-to-Severe Atopic Dermatitis: Addressing Healthcare Disparities in Urban Communities, Clinical and Managed Care Considerations in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Considerations in Addressing Underlying Inflammation, Evaluating Treatment Selections for Chronic Spontaneous Urticaria: Managed Care Considerations, Project ECHO: HR+/HER2- Metastatic Breast Cancer: What Can You Do to Optimize Patient Access to Cyclin-dependent Kinase 4 and 6 Inhibitors? Private Dining Room, Hilton Columbia Center division online orientation on deped memorandum no. RELEASED DATE: July 28, 2023 Apply to Education Coordinator, Medical Technician, Personal Assistant and more! This activity features education regarding hormone therapy for children and adolescents with growth hormone (GH) deficiency. This enduring activity discusses emerging treatments for advanced non-small cell lung cancer (NSCLC). EXPIRATION DATE: June 12, 2024, This enduring activity will enhance clinicians ability to identify evidence-based strategies to inform prompt diagnosis, treatment selection and adjustments and reduce the occurrence of exacerbations; improve the implementation of individualized treatment plans that include patient communication, education, and shared decision-making; and design treatment regimens that incorporate guideline recommendations and emerging clinical trial data. The Florida Board of Education approved a new set of standards for how Black history should be taught in the state's public schools, sparking criticism from education and civil rights advocates . Learn more about potential immune targets, systemic treatment strategies, and optimizing multidisciplinary management to individualize care in Non-Hodgkins Lymphoma. EXPIRATION DATE: June 09, 2024, This podcast will discuss the risks of severe disease in patients with obesity who develop COVID-19. Listen to a retina expert explain the rationale behind these new therapies, as well as the clinical trial data regarding their safety, efficacy, and mechanisms of action to expand treatment options and potentially improve visual outcomes in patients with retinal vascular conditions. EXPIRATION DATE: April 14, 2024, This Enduring of the DETECT Grand Rounds connects specialists with on-the-ground community HCPs to educate them on best practices for managing patients with early cognitive impairment and Alzheimers disease. Over the course of this activity there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Learners will evaluate the current burden of perianal fistula in Crohns disease, pathophysiology, and the characteristics of current and emerging mechanisms of therapy. 5. The CATALYST Initiative: Expanding Knowledge to Improve Clinical Decision-Making and Health Outcomes for Patients with Hematologic Malignancies: A Focus on CLL. Are you determined to provide excellent care with your talent, ambition, education and experience? The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. It provides a unique opportunity for learning about checkpoint inhibitor mechanisms in NSCLC, important biomarkers used to guide clinical decisions, and immune-related adverse events. Baltimore, MD 21202, Maggianos RELEASED DATE: October 25, 2022 An innovative simulation center will allow clinicians to apply what they have learned in an interactive, animated case. ACHE Newsletters. Learn more about potential immune targets, systemic treatment strategies, and optimizing multidisciplinary management to individualize care in Basal Cell Carcinoma (BCC). The Biometric Research Program is an integral component of NCI that supports NCI's overall mission by . A slide presentation will guide the learners in their selection of treatment strategies. Finally, this program will outline individualized management plans for patients with UFs based on new clinical guidance & shared decision-making. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. EXPIRATION DATE: July 21, 2024. RELEASED DATE: April 03, 2023 In this program; we will aim to discuss the cost burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach pharmacists how to apply best practices within the framework of interdisciplinary managed care of these patients. Phone Number +1 908-358-6466. Nashville, TN 37203, 5:15 AM 5:30 AM HST Registration & Breakfast EXPIRATION DATE: June 30, 2024, This enduring program will provide clinicians who care for patients with chronic lymphocytic leukemia and mantle cell leukemia with important updates about current and future management of the diseases. 908-358-6466. TeleECHO Sessions. Leveraging the Anti-Tumor Activity of the Immune System: Systemic Treatment for Advanced Non-Melanoma Skin Cancers, The Rationale and Role of CAR-T Therapy in Early Relapsed High-Risk Multiple Myeloma: Moving Advanced Therapy Forward in Hematologic Malignancies, The DETECT Initiative in Early Alzheimers Disease: Optimizing Collaboration and Multidisciplinary Care to Facilitate Timely Diagnosis Grand Rounds Series, Tackling Barriers to Care in Ophthalmology: Diversity, Equity and Inclusion in Academics, Research, and Clinical Practice, Updating Best Practices for Management of Advanced Melanoma Considering Current and Emerging Anti-LAG3 Combinations in the Veterans Affairs Setting, New Systemic Therapies for the Treatment of Patients with Advanced Non-Melanoma Skin Cancers, Tackling Barriers to Care in Ophthalmology: Diversity, Equity, and Inclusion in Academics, Research and Clinical Practice, Modifying Cardiovascular Risk Parameters Through Effective Management of Obesity and Relevant Comorbidities, Community Perspectives on JAK Inhibition for Inflammatory Bowel Disease Management: Addressing Gaps in Therapy, A part of the EMPOWER Initiative Current Concepts in the Management of Relapsed/Refractory Multiple Myeloma: Considerations With Bispecific Anti-BCMA Antibodies, Updating Outpatient Recommendations in COVID-19 Management: Identifying Opportunities for Risk Reduction in Non-Hospitalized Patient. RELEASED DATE: January 05 , 2023 The team at BJC respects your talent and ambition to succeed regardless of where you are in your career, which is why weve worked hard to streamline our hiring process. RELEASED DATE: March 31, 2023 6:00 6:15 PM Dinner/Registration Accredited by the ACCME with Commendation: Designing High Quality Educational Programs Resulting in Optimal Patient Care | Med Learning Group is a full-service accredited medical education company focusing on developing and implementing continuing education that improves healthcare practitioners' ability to provide optimal patient care. How Might Current Data Inform the Primary Care Physicians and the Multidisciplinary Teams Management of Cardiorenal Risk in Patients with Chronic Kidney Disease and Type 2 Diabetes? We aim to evaluate current strategies for the management of CKD in T2D using novel therapeutic agents that modify long-term clinical outcomes, including third-generation mineralocorticoid antagonists; describe current disparities in CKD care in T2D and strategies for integrating novel strategies in practice, including third-generation mineralocorticoid antagonists; and lastly to summarize safety data with novel agents in the management of CKD in T2D, including best practices for managing hyperkalemia with novel mineralocorticoid antagonists. Work closely with bedside teams and help mentor less . Perimeter Park South We make the world's best medicine better. Diagnosing and Managing Cold Agglutinin Disease in Clinical Practice: How Does Your Approach Compare with the Experts? RELEASED DATE: December 15, 2022 Sign-on bonus and relocation assistance available. Sign up for news and updates from Mercy Virtual. Nephrology Considerations in Reducing the Risk of Chronic Kidney Disease in Patients With Type 2 Diabetes: Up-to-Date Clinical Considerations With the Mineralocorticoid Antagonists, Current Perspectives on the Recognition and Prevention of Dengue Fever Worldwide: Novel Opportunities to Reduce Burden of Disease in 2022, Novel Therapeutic Perspectives in the Management of DLBCL: The Role of Antibody-Drug Conjugates and Bispecific Antibodies, Addressing Treatment Fatigue: Long-Acting Growth Hormone for the Pediatric Patient with GH Deficiency, Optimizing the Care of Patients with Relapsed/Refractory MCL and CLL/SLL in the Veterans Administration System: Evaluating Evidence-Based Management, Insights to Improve Responses to Immunotherapies: A Simulation Center Approach to Identifying Patients Who May Benefit from Predictive Biomarkers, Clinical Pearls for Community-based Oncologists Treating Patients with, New Insights on the Diagnosis and Treatment of Nonproliferative Diabetic Retinopathy, A Close Look at the Diagnosis and Treatment of Patients with Retinal Vascular Disease, From Vicious Cycle to Vicious Vortex: The Evolving Understanding of NCFBE Pathophysiology and Its Implications for Treatment, Personalized Therapy in Advanced Non-Small Cell Lung Cancer: Antibody Directed Treatment Targeting TROP2, HER3, and HER2, Hope on the Horizon: Emerging Treatment Options for Patients with Retinopathy of Prematurity. PARP Inhibitorbased Combinations for the Management of Patients with Metastatic Castration-resistant Prostate Cancer: What Are the Data Telling Us? RELEASED DATE: June 22, 2023 Features of this program include whiteboard animations and case studies. RELEASED DATE: December 1, 2022 This series of podcasts will elucidate the benefits and limitations of current therapeutic approaches for patients with nAMD or DME, equip participants with strategies for improving the durability of treatment response in patients receiving intravitreal therapies, and provide education on new and emerging treatment strategies. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Fighting the Flu: Clinical Pearls for Healthcare Professionals, IMPACT: Improving Outcomes in Patients with Familial Hypercholesterolemia: A Focus on Earlier Diagnosis, Treatment Selection, and Multi-Disciplinary Care, Updates and Best Practices Across Malignancies: Evaluating Therapeutic Developments and Optimizing Multidisciplinary Care in Non-Hodgkins Lymphoma. Thanks to the $496,349 USDA Distance Learning and Telemedicine Grants, Mercy Virtual will implement a project that includes hospitalists, emergency care, stroke and neurology services. EXPIRATION DATE: May 31, 2024, This podcast episode will focus on the overview of the disease state and talk about initial management strategies for patients with relapsed/refractory multiple myeloma. Learn more about jobs at Stryker. 2D animation technology is incorporated throughout the program to highlight the mechanism of action of point-of-care tests (POCTs) and antiviral treatments approved for treatment. With our offices located in Northern New Jersey, MedLearning operates in a geographic sphere of pharmaceutical talent that we retain as full time and free-lance employees to provide excellence in the services we offer. EXPIRATION DATE: January 31, 2024, This educational activity will assist the target HCPs ability to: assess the clinical advantages and disadvantages associated with luteinizing hormone-releasing hormone (LHRH) agonists and gonadotropin-releasing hormone (GnRH) antagonists used as androgen deprivation therapy (ADT) for patients with advanced prostate cancer (PC); evaluate the differential level of risk for cardiovascular adverse events when selecting ADT for patients with advanced PC; support equitable PC care through improved access to ADT and, finally, improve adherence to ADT through consideration of patient preferences regarding the route of administration. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in age-macular degeneration. EXPIRATION DATE: May 31, 2024, This Enduring of the DETECT Summit connects specialists with community healthcare providers to provide education on best practices for managing patients with early cognitive impairment and Alzheimers disease (AD). Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. Washington, DC 20015, Maggianos Little Italy Orlando Considerations in the Evaluation of Real-World Evidence for Patients with Multiple Myeloma: Efficacy and Safety Considerations to Inform Therapy, Decoding Biomarkers and Checkpoint Inhibitor Mechanisms in, Advances in the Management of Patients with. Website by. Wikipedia is an online encyclopedia written and maintained by a community of volunteers, known as Wikipedians, through open collaboration and using a wiki-based editing system called MediaWiki.Wikipedia is the largest and most-read reference work in history, and has consistently been one of the 10 most popular websites. A didactic presentation by expert faculty will review guideline recommendations and risk factors for complications, discuss pharmacologic and surgical treatment options, and examine clinical trial data on emerging agents. Over the course of this activity there will be discussion of the data from clinical trials assessing the clinical profiles of new systemic therapies with different mechanisms of action for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation; integrating methods for identifying and managing side effects associated with new systemic therapies for the treatment of patients with advanced NMSCs into routine clinical practice; categorizing the types of patients with unresectable NMSCs who may benefit from new systemic therapies for the treatment of advanced NMSCs; and lastly enhancing patient management including care coordination through participation in interdisciplinary care teams for those with advanced NMSCs failing or not amenable to surgery or radiation. TORONTO and PARK CITY, Utah, Jan. 3, 2023 /PRNewswire/ -- DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announces the completion of its investment in Med Learning. RELEASED DATE: December 5, 2022 USDA awards Mercy $496,349 grant benefitting rural communities in four states ST. LOUIS For the fourth time, the USDA has awarded Mercy a substantial grant that will provide greater access to health care in some of Mercys most rural communities in Arkansas, Kansas, Missouri and Oklahoma. Participants will be equipped with an enhanced ability to apply current guideline recommendations and clinical data to management plans, personalize diabetes treatment for older adults in long-term care facilities and in the community, and gain greater knowledge of the rationale for using fixed ratio combinations of basal insulin and GLP-1 receptor agonists in older adults with T2DM. Copyright 2023 Med Learning Group. RELEASED DATE: February 22, 2023 The program will discuss the diagnosis of GH deficiency, challenges of currently available therapies, clinical data of emerging therapies, and strategies to personalize care for childhood growth hormone deficiency (CGHD). Learners will also recognize the need for implementing guideline-based management of obesity across providers and increase their comfort with the integration of weight reduction pharmacotherapy. RELEASED DATE: March 17, 2023 RELEASED DATE: May 01, 2023 RELEASED DATE: October 7, 2022 RELEASED DATE: May 01, 2023 Visualizing Mechanisms of Bispecific Antibodies in Large B-Cell Lymphomas: Current Efficacy and Safety Data for Application in Relapsed/Refractory Populations, Clinical Practice Pearls: Managing Patients with Major Depressive Disorder Showing an Inadequate Response to First-Line Therapies. Expert faculty will review the latest information on clinical presentation, treatment recommendations, and clinical trial data on available therapies to help learners reduce both short- and long-term consequences of disease. Identify patients in their own practice who may potentially benefit from treatments targeting GIP and GLP-1 receptors in the future based on knowledge of recent clinical data, Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists, Identify patients with type 2 diabetes who are most likely to benefit from the use of GLP-1 receptor agonists, Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data, Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM, Develop treatment regimens that address the immunological and neural components of prurigo nodularis (PN), Integrate patient-specific factors, such as quality of life and comorbidities, into the selection of treatment options for the management of PN, Assess clinical trial data on the efficacy and safety of emerging therapies for the treatment of PN, Discuss the elements of immune dysfunction that drive the tumorigenesis of cutaneous squamous cell carcinoma (cSCC), Review risk stratification of patients with cutaneous squamous cell carcinoma to determine who are at high risk of recurrence, Describe the application of medical practice guidelines and supporting trial data to the treatment of patients with locally advanced and metastatic cSCC, Interpret data from studies exploring the safety/toxicity profiles of IO/TKI combination therapies used to treat patients with advanced solid tumors, Develop strategies to manage the irAEs and trAEs associated IO/TKI combination therapies used for the treatment of patients with advanced solid tumors, Support multidisciplinary team approaches for the diagnosis and management of irAEs in patients with advanced solid tumors treated with combination IO/TKI therapies, Describe the immune cells and proinflammatory proteins that represent therapeutic targets in SLE including BAFF, type 1 interferon, and cytokines associated with JAK/STAT signaling, Explain how dysregulated innate and adaptive immune responses lead to specific clinical manifestations and disease consequences in patients with SLE, Evaluate the safety and efficacy of new and emerging SLE therapies that target its pathogenetic pathways, Select treatments for patients with SLE based on their pathogenic rationale. Learn more about factors that can help determine when systemic therapy is appropriate, available, and emerging systemic treatment options, and elements of multidisciplinary care to enhance your management approach in NMSC. EXPIRATION DATE: April 19, 2024, The educational activity focuses on the role of GLP-1 receptor agonists in the care of patients with type 2 diabetes, including but not limited to, the glycemic and extra-glycemic effects and strategies to avoid adverse events of GLP-1 receptor agonists while enhancing the patient/provider partnership using a shared decision-making approach to the selection of GLP-1 receptor agonists. EXPIRATION DATE: October 06, 2023, This program will discuss tumorigenesis in advanced non-small cell lung cancer (NSCLC) and the mechanism of actions of checkpoint inhibitors, the latest clinical data describing the efficacy and safety of first-line use of PD-1 inhibitor therapy, alone and in combination, and the use of immunotherapy in the first-line treatment of NSCLC with no actionable mutations. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded . This interactive online activity will explore the diagnosis and management of hypertrophic cardiomyopathy (HCM). RELEASED DATE: December 21, 2022 Using Targeted Treatment Options for the Management of BRAF-mutant Metastatic Colorectal Cancer: How Does Your Approach Compare with the Experts?
Visiting Stockbridge, Ma,
Does Yogurt Bark Melt,
Are Colliers And Cbre The Same Company,
Red Sox And Tigers Players,
Articles M
